Accueil/Actions/MIRA

MIRA

USD

MIRA Pharmaceuticals Inc. Common Stock

$1.570-0.120 (-7.101%)

Prix en Temps Réel

Healthcare

Drug Manufacturers - General

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.690

Haut

$1.725

Bas

$1.560

Volume

0.04M

Fondamentaux de l'Entreprise

Capitalisation Boursière

32.7M

Industrie

Drug Manufacturers - General

Pays

United States

Statistiques de Trading

Volume Moyen

3.18M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.73Actuel $1.570Haut $2.45

Actualités Connexes

24 oct. 2025 · 11:30

AccessWire

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / October 24, 2025 /

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

Actions Connexes

TCBI

Texas Capital Bancshares Inc.

NASDAQ

Grandes banques

BLIN

Bridgeline Digital Inc.

NASDAQ

Logiciels infor...

CALM

Cal-Maine Foods Inc.

NASDAQ

Farming/Seeds/M...

AVY

Avery Dennison Corporation

NASDAQ

Containers/Pack...

USB

U.S. Bancorp

NASDAQ

Grandes banques

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.